Skip to content

Applying Artificial Intelligence to Identify Subphenotypes of Acute Kidney Injury in Mexican Patients With Severe COVID-19

Applying Artificial Intelligence to Identify Subphenotypes of Acute Kidney Injury in Mexican Patients With Severe COVID-19

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06471101
Acronym
IA-COVAKI
Enrollment
2934
Registered
2024-06-24
Start date
2024-06-18
Completion date
2024-06-18
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Kidney Injury, COVID-19

Keywords

machine learning, artificial intelligence

Brief summary

The goal of this observational study was to identify subphenotypes of acute kidney injury patients with COVID-19, and the investigators analyzed their impact on mortality. The study included demographic and clinical variables of the participants. The implementation of Machine Learning algorithms and Artificial Intelligence methods are used, and some specific implementations were designed for the analysis, where each group was characterized by traditional statistical methods.

Interventions

DIAGNOSTIC_TESTclusters

clustering

Sponsors

Instituto Nacional de Enfermedades Respiratorias
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
15 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients older than 15 years old, hospitalized, and with severe acute respiratory syndrome (SARS-CoV-2) positive confirmation.

Exclusion criteria

* Patients who did not have at least 1 creatinine measurement.

Design outcomes

Primary

MeasureTime frameDescription
Subphenotypes of acute kidney injury in patientsThrough study completion, an average of one monthNumber of acute kidney injury subphenotypes in patients with COVID-19

Secondary

MeasureTime frameDescription
Mortality of acute kidney injury patientsThrough study completion, an average of one monthDifferences between mortality rates in acute kidney injury subphenotypes of patients with COVID-19
Severity of acute kidney injury patientsThrough study completion, an average of one monthDifferences between severity stages in acute kidney injury subphenotypes of patients with COVID-19
Non-recovery in acute kidney injury patientsThrough study completion, an average of one monthDifferences between non recovery rates in acute kidney injury subphenotypes of patients with COVID-19
Renal replacement therapy requirement in acute kidney injury patientsThrough study completion, an average of one monthDifferences between renal replacement therapy requirement rates in acute kidney injury subphenotypes of patients with COVID-19
Length of stay of acute kidney injury patientsThrough study completion, an average of one monthDifferences in-hospital length of stay in acute kidney injury subphenotypes of patients with COVID-19.

Countries

Mexico

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026